abiraterone,[lu-177]-pnt2002,enzalutamide
janssen,pfizer,astellas,point biopharma
['pnt2002', 'splash', 'pnt2002 ', 'prostate', '$pnt']
$pnt published a poster at esmo congress 2022 highlighting updated safety and efficacy data from its phase 3 splash trial of pnt2002 in metastatic castration-resistant prostate cancer.
MAISA's Platform is based  MAISA's proprietary Optimization on Mathematical Probability Algorithm (OMPA) which derived majority from applied mathematics.